Cancers with high TMB include melanoma, lung cancer, bladder cancer, and certain types of colorectal cancer. These cancers often have a high number of mutations due to factors such as environmental exposure or genetic predispositions, making them more likely to express neoantigens that can be targeted by the immune system.